Cherry Biotech

We are convinced that the technological convergence of Microfluidic Organ-On-Chip, Multi-omics, the most advanced imaging techniques and artificial intelligence will allow to better predict drugs effects on the human body and bring the possibility to replace animal testing. Our mission is to develop a technological platform combining microfluidic technology, artificial intelligence, and the most advanced imaging techniques allowing the scientific paradigm shift from animal to 3D In vitro toxicology and efficacy prediction. Our mission is to develop an Organ-On-Chip platform that will provide massive and high-quality biological data coming from Multi-Omic analysis & the most advanced imaging techniques. We are all passionate about improving human health and animal wellfare. To succeed in our mission, we have also built a strong culture based on 3 major axes :. We provide both standard and customized in vitro studies that can be used to screen your new therapeutic candidates, explore the mechanisms of action of drugs or biologics, and accelerate the design of clinical trials. Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing. To reduce and replace animal testing to predict drugs effects on human body, we are convinced that we can reach the full potential of drug prediction by combining Artificial Intelligence, Microfluidic instruments, Multi Omic Sensors and High-resolution live Imaging.